Essilor released its Q4 17 results which were ahead of our estimates as well as the street’s expectations. Like-for-like revenue growth accelerated to 5.1% (vs. Q3 17: +2.5%; 150bp above AV’s estimate) on the back of strong growth momentum in the Lenses and Optical Instruments segment (+5.2%; c.85% of Q4 17 sales). Within the segment, North America was the key growth contributor (+8.8%; c.36% of Q4 17 sales), benefiting from the successful launch of the Varilux X series and Crizal
06 Apr 2018
Strong acceleration in Q4 driven by North America; deal completion by Q2 18
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong acceleration in Q4 driven by North America; deal completion by Q2 18
EssilorLuxottica SA (EI:WBO) | 0 0 1.9% | Mkt Cap: 24,290m
- Published:
06 Apr 2018 -
Author:
Sumit Sayal -
Pages:
3
Essilor released its Q4 17 results which were ahead of our estimates as well as the street’s expectations. Like-for-like revenue growth accelerated to 5.1% (vs. Q3 17: +2.5%; 150bp above AV’s estimate) on the back of strong growth momentum in the Lenses and Optical Instruments segment (+5.2%; c.85% of Q4 17 sales). Within the segment, North America was the key growth contributor (+8.8%; c.36% of Q4 17 sales), benefiting from the successful launch of the Varilux X series and Crizal